April 25, 2017


Game Changer? First Malaria Vaccine to Begin Field Tests in Africa

The World Health Organization has commenced field testing on the first ever malaria vaccine, to determine whether it is possible to cure infected children in impoverished Africa.

After decades of research, the first malaria vaccine is here, the World Health Organization announced Monday. Developed by GlaxoSmithKline, a British pharmaceutical giant, it has shown promising"...

Continue Reading >

April 24, 2017


Leading US laboratories invited to develop their investments in Algeria

Algeria and the United States have agreed, Sunday in Algiers, to encourage American leading laboratories to develop their investments in Algeria, following the audience granted by Minister of Health, Population and Hospital Reform Abdelmalek Boudiaf to Assistant US Trade Representative for Europe and the Middle East Daniel Lawrence Mullaney.

During the discussions, attended by the US Ambassador to Algeria, the two sides agreed to 'jointly work"...

Continue Reading >

April 20, 2017


Sellal inaugurates injectable cephalosporin antibiotics plant in Oran

Prime Minister Abdelmalek Sellal inaugurated Wednesday a plant producing injectable cephalosporin antibiotics in Oran, where he is on a working visit.

The plant producing the antibiotics, planted in Hassi Ben Okba, Oran (432-km west of Algiers), belongs to the Algerian Pharmaceutical Company (SOPHAL).

It will cut imports of the injectable cephalosporin antibiotics, which"...

Continue Reading >

April 20, 2017


Replicor discloses achievement of 1 year functional control of HBV and HDV with NAPs and new mechanistic insights in NAP pharmacology

Replicor Inc., a privately held biopharmaceutical company targeting a cure for chronic HBV and HDV infection, today disclosed significant new data on NAP activity in HBV and HDV infections at the European Association for the Study of the Liver (EASL) 2017 annual meeting held April 19-23, 2017 in Amsterdam, The Netherlands.

Updates in the REP 301 (HBV/HDV coinfection) and REP 401 (HBV infection) studies demonstrated important advances:


Continue Reading >

April 19, 2017


Creation of pharmaceutical cluster in Constantine under consideration

The creation of a pharmaceutical cluster in Constantine (431-km east of Algiers) is currently under consideration, said Tuesday Minister of Industry and Mining Abdesslam Bouchouareb.

'The State has already developed a mechanical engineering cluster in Constantine and another specialized in chemical industry in Oran (432-km west of Algiers), and the main objective today is the creation of a drug industry cluster in the city of bridges,' said"...

Continue Reading >

April 19, 2017


AED 1.45 billion Julphar sales in 2016

Led by its Chairman His Highness Sheikh Faisal Bin Saqr Al Qasimi, Julphar’s General Assembly Meeting took place in the company’s headquarters of Ras Al Khaimah on April 16th. During the meeting, the General Assembly decided to distribute 16 per cent of profits in cash in addition to 3 per cent in shares to shareholders.

“In the middle of the political"...

Continue Reading >

April 15, 2017


Some 1450 specialist doctors for southern provinces

Some 1450 specialist doctors will be posted to southern provinces as part of civil service, said Thursday in Algiers Minister of Health, Population and Hospital Reform Abdelmalek Boudiaf.

In reply to oral questions of members of the Council of the Nation (Upper House of Parliament) during a plenary session chaired by Speaker Abdelkader Bensalah, Boudiaf said that 1450 specialist doctors, out of a total of 2400 that will graduate in 2017, would"...

Continue Reading >

April 12, 2017


PSMF Invites International Patient Safety Community to Attend its 5th Annual Midyear Planning Meeting on July 13, 2017

The Patient Safety Movement Foundation (PSMF) invites patient safety experts, medical care providers, hospital administrators, patient advocates and policy makers from around the world to discuss challenges, brainstorm solutions and plan next steps in the mission to attain zero preventable deaths by the year 2020. Like the last midyear planning meeting, this meeting is principally a working meeting with the goal of solidifying our objectives for the next year. This meeting is by invitation only and will be co-convened with the Inova Heart & Vascular Institute at the Inova Center for Personalized Health in Falls Church, Virginia on July 13, 2017, from 9:00 am to 6:30 pm. Attendees will be provided preparation materials in advance of the meeting so they can prepare for a fruitful discussion. Meeting registration is complimentary; however space is limited to 100 registrants. Please request......

Continue Reading >

April 10, 2017


Fresenius Medical Care AG & Co. KGaA Published Form 20-F for the Fiscal Year 2016 

Fresenius Medical Care AG & Co. KGaA ("the company" or "Fresenius Medical Care"), the world's largest provider of dialysis products and services, announced that it has filed the annual report 2016 under form 20-F with the U.S. Securities and Exchange Commission (SEC). The report is available at the company's website ...

Continue Reading >

April 9, 2017


Julphar Announces Full Year 2016 Financial Results

Julphar Gulf Pharmaceutical Industries, the largest generic pharmaceutical manufacturer in Middle East and North Africa (MENA), announced it has closed the year 2016 with sales of AED 1.45 billion.Despite the challenging and rapidly changing market environment, Julphar continued to perform strongly, which demonstrates the company’s solid and stable foundation. Julphar’s operating profit stood at AED 229 million and the net profit for the period was AED 210 million.Commenting on the annual results for 2016, Julphar’s Chief Financial Officer Jerome Carle said: “2016 was another year of great achievements for Julphar and I am confident that the company is equipped to take on new opportunities that will come our way in 2017. As one of the UAE’s most ambitious company, Julphar is now expanding to maximize presence in the region and strives to make an impact in the global stage, with the finalization of our world-class manufacturing facility in Saudi Arabia later this month.”“This expansion has been possible thanks to the dedication......

Continue Reading >

Forex Market Video